AMERISEPlastic Products - Industrial
Amerise Biosciences Ltd — Balance Sheet
₹0.59
-4.62%
Amerise Biosciences Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 6.61 Cr | 6.61 Cr | 6.61 Cr | 6.61 Cr | — |
| Share Issued | 6.61 Cr | 6.61 Cr | 6.61 Cr | 6.61 Cr | — |
| Total Debt | 0.00 | 0.00 | 0.09 Cr | 0.08 Cr | — |
| Tangible Book Value | 5.38 Cr | 5.37 Cr | 5.52 Cr | 5.64 Cr | — |
| Invested Capital | 5.38 Cr | 5.37 Cr | 5.61 Cr | 5.72 Cr | — |
| Working Capital | -3.06 Cr | 74000.00 | -0.02 Cr | -0.04 Cr | — |
| Net Tangible Assets | 5.38 Cr | 5.37 Cr | 5.52 Cr | 5.64 Cr | — |
| Common Stock Equity | 5.38 Cr | 5.37 Cr | 5.52 Cr | 5.64 Cr | — |
| Total Capitalization | 5.38 Cr | 5.37 Cr | 5.61 Cr | 5.72 Cr | — |
| Total Equity Gross Minority Interest | 5.38 Cr | 5.37 Cr | 5.52 Cr | 5.64 Cr | — |
| Stockholders Equity | 5.38 Cr | 5.37 Cr | 5.52 Cr | 5.64 Cr | — |
| Other Equity Interest | -1.23 Cr | -1.23 Cr | -1.09 Cr | -0.97 Cr | — |
| Capital Stock | 6.61 Cr | 6.61 Cr | 6.61 Cr | 6.61 Cr | — |
| Common Stock | 6.61 Cr | 6.61 Cr | 6.61 Cr | 6.61 Cr | — |
| Total Liabilities Net Minority Interest | 3.08 Cr | 0.02 Cr | 0.13 Cr | 6.35 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.09 Cr | 0.08 Cr | — |
| Long Term Debt And Capital Lease Obligation | 0.00 | 0.00 | 0.09 Cr | 0.08 Cr | — |
| Long Term Debt | 0.00 | 0.00 | 0.09 Cr | 0.08 Cr | — |
| Current Liabilities | 3.08 Cr | 0.02 Cr | 0.04 Cr | 6.27 Cr | — |
| Other Current Liabilities | 0.03 Cr | 0.02 Cr | 0.04 Cr | 50000.00 | — |
| Current Debt And Capital Lease Obligation | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Debt | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Provisions | 19000.00 | — | — | 10000.00 | 10000.00 |
| Payables | 0.00 | 0.02 Cr | 0.04 Cr | 6.27 Cr | — |
| Total Tax Payable | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Accounts Payable | 0.00 | 0.00 | 0.00 | 6.27 Cr | — |
| Total Assets | 8.46 Cr | 5.39 Cr | 5.65 Cr | 11.99 Cr | — |
| Total Non Current Assets | 8.44 Cr | 5.37 Cr | 5.63 Cr | 5.76 Cr | — |
| Non Current Deferred Taxes Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investmentin Financial Assets | 2.38 Cr | 2.27 Cr | 4.57 Cr | 4.69 Cr | — |
| Available For Sale Securities | 2.38 Cr | 2.27 Cr | 4.57 Cr | 4.69 Cr | — |
| Long Term Equity Investment | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Gross PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Construction In Progress | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 0.03 Cr | 0.02 Cr | 0.01 Cr | 6.23 Cr | — |
| Other Current Assets | 47000.00 | 18000.00 | — | -1000.00 | — |
| Assets Held For Sale Current | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Accounts Receivable | 0.00 | 0.00 | 0.00 | 6.22 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.02 Cr | 0.02 Cr | 0.01 Cr | 0.01 Cr | — |
| Other Short Term Investments | 0.01 Cr | 92000.00 | 7000.00 | 9000.00 | — |
| Cash And Cash Equivalents | 0.01 Cr | 0.02 Cr | 0.01 Cr | 0.01 Cr | — |
| Retained Earnings | — | -1.31 Cr | -1.17 Cr | -1.05 Cr | -1.60 Cr |
| Additional Paid In Capital | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Current Deferred Taxes Liabilities | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Payable | — | 0.02 Cr | 0.04 Cr | 10000.00 | — |
| Investments In Other Ventures Under Equity Method | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 18000.00 | 0.00 | — | — |
| Taxes Receivable | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Financial | — | 0.02 Cr | 0.01 Cr | 0.01 Cr | 0.02 Cr |
| Treasury Shares Number | — | — | 0.00 | — | — |
| Net Debt | — | — | 0.08 Cr | 0.07 Cr | — |
| Other Non Current Liabilities | — | — | — | -1000.00 | — |
| Other Non Current Assets | — | — | — | -1000.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Amerise Biosciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.